Alvotech S.A. is a global biopharmaceutical company specializing in the development, manufacturing, and delivery of high-quality biosimilar medicines. Biosimilars are biologic products highly similar ... Alvotech S.A. is a global biopharmaceutical company specializing in the development, manufacturing, and delivery of high-quality biosimilar medicines. Biosimilars are biologic products highly similar to approved reference medicines, designed to expand patient access to affordable treatments for conditions in areas such as oncology, immunology, and autoimmune diseases. The company employs a vertically integrated approach, managing processes from cell line development through fill-and-finish manufacturing, which enables control over quality, scale, and efficiency. Alvotech maintains a robust pipeline of biosimilar candidates targeting major therapeutic needs and relies on strategic partnerships with pharmaceutical companies for global commercialization. This model supports its mission to make proven biologic therapies accessible to patients worldwide. Founded in 2013 and headquartered in Reykjavik, Iceland, Alvotech focuses on producing cost-competitive alternatives that meet rigorous standards while enhancing healthcare outcomes through expanded availability of essential medicines.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Financial Fundamentals data not yet covered for Alvotech

We have not yet reviewed Alvotech's disclosures for Financial Fundamentals data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Alvotech's data?

Start your 30-day free trial to request a data review for Alvotech.

Start Free Trial

Legal Center Contact Us

Alvotech SA

Financial Fundamentals data not yet covered for Alvotech

Account Restricted